company background image
FAE logo

Faes Farma BME:FAE Voorraadrapport

Laatste prijs

€3.45

Marktkapitalisatie

€1.1b

7D

-2.1%

1Y

8.5%

Bijgewerkt

21 Nov, 2024

Gegevens

Financiële gegevens bedrijf +

Faes Farma, S.A. Concurrenten

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Faes Farma
Historische aandelenkoersen
Huidige aandelenkoers€3.45
52 Week Hoogtepunt€3.83
52 Week Laag€2.91
Bèta0.50
11 maand verandering-5.87%
3 maanden verandering-5.36%
1 Jaar Verandering8.50%
33 jaar verandering1.62%
5 jaar verandering-35.97%
Verandering sinds IPO239.78%

Recent nieuws en updates

Faes Farma, S.A. (BME:FAE) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Nov 03
Faes Farma, S.A. (BME:FAE) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Faes Farma, S.A. (BME:FAE) Just Released Its Full-Year Earnings: Here's What Analysts Think

Mar 01
Faes Farma, S.A. (BME:FAE) Just Released Its Full-Year Earnings: Here's What Analysts Think

Recent updates

Faes Farma, S.A. (BME:FAE) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Nov 03
Faes Farma, S.A. (BME:FAE) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Faes Farma, S.A. (BME:FAE) Just Released Its Full-Year Earnings: Here's What Analysts Think

Mar 01
Faes Farma, S.A. (BME:FAE) Just Released Its Full-Year Earnings: Here's What Analysts Think

Faes Farma (BME:FAE) Is Due To Pay A Dividend Of €0.0316

Dec 18
Faes Farma (BME:FAE) Is Due To Pay A Dividend Of €0.0316

Faes Farma (BME:FAE) Will Pay A Dividend Of €0.0316

Dec 04
Faes Farma (BME:FAE) Will Pay A Dividend Of €0.0316

Does Faes Farma (BME:FAE) Have A Healthy Balance Sheet?

Nov 24
Does Faes Farma (BME:FAE) Have A Healthy Balance Sheet?

Here's Why Faes Farma (BME:FAE) Can Manage Its Debt Responsibly

May 03
Here's Why Faes Farma (BME:FAE) Can Manage Its Debt Responsibly

Is There An Opportunity With Faes Farma, S.A.'s (BME:FAE) 50% Undervaluation?

Sep 21
Is There An Opportunity With Faes Farma, S.A.'s (BME:FAE) 50% Undervaluation?

Is Faes Farma (BME:FAE) A Risky Investment?

Aug 03
Is Faes Farma (BME:FAE) A Risky Investment?

Faes Farma (BME:FAE) Ticks All The Boxes When It Comes To Earnings Growth

Jun 17
Faes Farma (BME:FAE) Ticks All The Boxes When It Comes To Earnings Growth

Is Faes Farma (BME:FAE) Using Too Much Debt?

Mar 27
Is Faes Farma (BME:FAE) Using Too Much Debt?

Faes Farma (BME:FAE) Is Increasing Its Dividend To €0.14

Dec 13
Faes Farma (BME:FAE) Is Increasing Its Dividend To €0.14

Faes Farma's (BME:FAE) Dividend Will Be Increased To €0.17

Nov 29
Faes Farma's (BME:FAE) Dividend Will Be Increased To €0.17

Is Faes Farma (BME:FAE) A Risky Investment?

Sep 21
Is Faes Farma (BME:FAE) A Risky Investment?

Faes Farma, S.A. (BME:FAE) Interim Results: Here's What Analysts Are Forecasting For This Year

Jul 31
Faes Farma, S.A. (BME:FAE) Interim Results: Here's What Analysts Are Forecasting For This Year

Is Faes Farma (BME:FAE) Using Too Much Debt?

May 01
Is Faes Farma (BME:FAE) Using Too Much Debt?

Estimating The Fair Value Of Faes Farma, S.A. (BME:FAE)

Apr 07
Estimating The Fair Value Of Faes Farma, S.A. (BME:FAE)

Does Faes Farma, S.A. (BME:FAE) Have A Place In Your Dividend Portfolio?

Mar 22
Does Faes Farma, S.A. (BME:FAE) Have A Place In Your Dividend Portfolio?

Faes Farma's (BME:FAE) Solid Earnings May Rest On Weak Foundations

Mar 06
Faes Farma's (BME:FAE) Solid Earnings May Rest On Weak Foundations

Faes Farma (BME:FAE) Has Compensated Shareholders With A Respectable 61% Return On Their Investment

Feb 22
Faes Farma (BME:FAE) Has Compensated Shareholders With A Respectable 61% Return On Their Investment

I Ran A Stock Scan For Earnings Growth And Faes Farma (BME:FAE) Passed With Ease

Jan 16
I Ran A Stock Scan For Earnings Growth And Faes Farma (BME:FAE) Passed With Ease

Faes Farma (BME:FAE) Seems To Use Debt Rather Sparingly

Dec 08
Faes Farma (BME:FAE) Seems To Use Debt Rather Sparingly

Rendement voor aandeelhouders

FAEES PharmaceuticalsES Markt
7D-2.1%-3.8%0.5%
1Y8.5%9.0%15.3%

Rendement versus industrie: FAE presteerde slechter dan de Spanish Pharmaceuticals -sector, die het afgelopen jaar een rendement van 9 % opleverde.

Rendement versus markt: FAE presteerde slechter dan Spanish Market, dat het afgelopen jaar een rendement van 15.3 % opleverde.

Prijsvolatiliteit

Is FAE's price volatile compared to industry and market?
FAE volatility
FAE Average Weekly Movement1.8%
Pharmaceuticals Industry Average Movement4.1%
Market Average Movement3.0%
10% most volatile stocks in ES Market5.4%
10% least volatile stocks in ES Market0.6%

Stabiele aandelenkoers: FAE heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 2% ) van FAE is het afgelopen jaar stabiel geweest.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
19331,762n/afaesfarma.com

Faes Farma, S.A., onderzoekt, ontwikkelt, produceert en verkoopt farmaceutische producten, gezondheidsproducten en grondstoffen wereldwijd. Het bedrijf opereert via de segmenten Farmaceutische Producten en Gezondheidszorgspecialiteiten; Diervoeding en Gezondheid; en Farmaceutische Grondstoffen. Het biedt producten voor verschillende therapeutische gebieden.

Faes Farma, S.A. Samenvatting

Hoe verhouden de winst en inkomsten van Faes Farma zich tot de beurswaarde?
FAE fundamentele statistieken
Marktkapitalisatie€1.07b
Inkomsten(TTM)€97.59m
Inkomsten(TTM)€504.04m

11.0x

Koers/Winstverhouding

2.1x

P/S-verhouding

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
FAE resultatenrekening (TTM)
Inkomsten€504.04m
Kosten van inkomsten€169.88m
Brutowinst€334.16m
Overige uitgaven€236.57m
Inkomsten€97.59m

Laatst gerapporteerde inkomsten

Sep 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)0.31
Brutomarge66.30%
Nettowinstmarge19.36%
Schuld/Eigen Vermogen Verhouding6.9%

Hoe presteerde FAE op de lange termijn?

Bekijk historische prestaties en vergelijking

Dividenden

4.5%

Huidig dividendrendement

37%

Uitbetalingsratio